LPL Financial’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,666
Closed -$316K 5072
2023
Q4
$316K Sell
10,666
-5,381
-34% -$107K ﹤0.01% 4047
2023
Q3
$255K Buy
16,047
+2,223
+16% +$37K ﹤0.01% 4058
2023
Q2
$261K Sell
13,824
-5,411
-28% -$63.9K ﹤0.01% 3968
2023
Q1
$73.9K Buy
19,235
+7,829
+69% +$33.4K ﹤0.01% 4257
2022
Q4
$56.6K Sell
11,406
-50,680
-82% -$275K ﹤0.01% 4245
2022
Q3
$297K Buy
62,086
+443
+0.7% +$2.33K ﹤0.01% 3604
2022
Q2
$277K Buy
61,643
+1,110
+2% +$4.82K ﹤0.01% 3693
2022
Q1
$288K Buy
60,533
+127
+0.2% +$703 ﹤0.01% 3588
2021
Q4
$448K Buy
60,406
+5,636
+10% +$35K ﹤0.01% 3374
2021
Q3
$311K Buy
54,770
+19,256
+54% +$111K ﹤0.01% 3620
2021
Q2
$234K Buy
35,514
+2,608
+8% +$18.2K ﹤0.01% 3789
2021
Q1
$267K Buy
32,906
+335
+1% +$2.73K ﹤0.01% 3563
2020
Q4
$210K Sell
32,571
-3,238
-9% -$18.9K ﹤0.01% 3486
2020
Q3
$129K Sell
35,809
-8,474
-19% -$34.2K ﹤0.01% 3320
2020
Q2
$204K Buy
44,283
+14,335
+48% +$61K ﹤0.01% 3119
2020
Q1
$102K Buy
29,948
+2,150
+8% +$9.4K ﹤0.01% 2991
2019
Q4
$142K Sell
27,798
-4,945
-15% -$16.8K ﹤0.01% 3179
2019
Q3
$79K Sell
32,743
-1,391
-4% -$3.69K ﹤0.01% 3169
2019
Q2
$74K Buy
34,134
+498
+1% +$1.18K ﹤0.01% 3178
2019
Q1
$91K Sell
33,636
-271
-0.8% -$1.17K ﹤0.01% 3081
2018
Q4
$163K Buy
33,907
+2,008
+6% +$12.2K ﹤0.01% 2868
2018
Q3
$302K Sell
31,899
-155
-0.5% -$1.49K ﹤0.01% 2696
2018
Q2
$312K Sell
32,054
-5,973
-16% -$63K ﹤0.01% 2614
2018
Q1
$400K Sell
38,027
-7,967
-17% -$78.7K ﹤0.01% 2351
2017
Q4
$295K Sell
45,994
-5,782
-11% -$35.7K ﹤0.01% 2514
2017
Q3
$396K Buy
+51,776
New +$344K ﹤0.01% 2128

Other funds holding IMGN

LPL Financial's IMGN Position: Q1 2024 in Review

LPL Financial sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 10,666 shares — an estimated $316K sold.

LPL Financial first reported a position in IMGN in Q3 2017 and held it in 26 quarters. The position peaked at $448K in Q4 2021. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • LPL Financial reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • LPL Financial sold 10,666 Immunogen Inc shares in Q1 2024, an estimated $316K.
  • LPL Financial first reported a position in Immunogen Inc in Q3 2017 and held it in 26 quarters.
  • LPL Financial's Immunogen Inc position peaked at $448K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on LPL Financial's 13F filing for Q1 2024, filed 10 May 2024.